fda compounding glp-1 warning letters october 2025 Last month, the issued 25 to telehealth companies over what it called false or misleading claims about compounded medications. Read more at the link in the comments below FDA Warns 25 Firms Over

GHK-CU demonstrates potent anti-inflammatory properties, helping reduce chronic inflammationa key driver of aging and metabolic diseasewhile supporting immune balance

GLP-1s Two major GLP-1 alternatives are: dulaglutide (Trulicity) tirzepatide (Mounjaro, Zepbound) Trulicity and Mounjaro are both FDA-approved to manage type 2 diabetes by improving blood sugar

Gout generally goes through stages of severity

peptide therapy (Body Protection Compound-157) is a peptide derived from a protein found in your gastric juice

BMI 25.0 to 26.9 (overweight, below threshold)

GEP44 activates insulin-independent glucose uptake in muscle tissue via its interactions with Y1-R Despite the positive ISR data and hypothesis that GEP12 would prove superior to GEP44, we noted in in vivo studies (vide infra) that it was considerably inferior to GEP44 in terms of food intake and body weight reduction